Lurasidon Teva 18,5 mg filmom obložene tablete
| Name | Lurasidon Teva 18,5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-247238793 |
| Active Substance | lurasidonklorid |
| Composition | jedna filmom obložena tableta sadrži lurasidonklorid što odgovara 18,6 mg lurasidona |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Teva Operations Poland Sp. z o.o., Krakow, Poljska Elpen Pharmaceutical Co.Inc. (SA), Pikermi, Attica, Grčka |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 13.06.2024 |
| MA Period of Validity | 13.06.2029 |
| Classification Number | UP/I-530-09/23-01/102 |
| Registration Number | 381-12-01/171-24-08 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N05AE05 |
| SmPC | download |
| PL | download |
